WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--Sept. 15, 2006--Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that it will present at The Wall Street Analyst Forum's 17th Annual Analyst Conference to be held at The Princeton Club, 15 West 43rd Street (between 5th and 6th), New York, NY, from September 27-29, 2006. Mr. Richard T. Schumacher, PBI Founder, President, and CEO will give a corporate overview at 11:50 am on Wednesday, September 27, 2006. Investors will be able to see and hear the presentation at: www.investorcalendar.com.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.
Forward Looking Statements
Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended June 30, 2006, in the Company's Annual Report on Form 10-KSB, as amended, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
Visit us at our website http://www.pressurebiosciences.com
CONTACT: Pressure BioSciences, Inc.
Richard T. Schumacher
Edward H. Myles
508-580-1818 (T)
SOURCE: Pressure BioSciences